title: A case of community-acquired Acinetobacter baumannii meningitis - has the threat moved beyond the hospital?
abstract: Acinetobacter baumannii is a prolific nosocomial pathogen renowned for its multidrug-resistant nature. We report a case of community-acquired meningitis due to A. baumannii. The case highlights the potential pathogenicity of this organism and raises concerns that this highly adaptable organism may soon evolve into a significant community pathogen, too.
authors.affiliation: Division of Clinical Microbiology and Infectious Diseases, National Health Laboratory Services and Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
authors.forename: Warren
authors.initials: W
authors.lastname: Lowman
authors.affiliation: Department of Internal Medicine, Helen Joseph Hospital, Johannesburg, South Africa.
authors.forename: Thomas
authors.initials: T
authors.lastname: Kalk
authors.affiliation: Department of Internal Medicine, Helen Joseph Hospital, Johannesburg, South Africa.|Division of Clinical Microbiology and Infectious Diseases, National Health Laboratory Services and Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
authors.forename: Colin N
authors.initials: CN
authors.lastname: Menezes
authors.affiliation: Division of Clinical Microbiology and Infectious Diseases, National Health Laboratory Services and Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
authors.forename: Melanie A
authors.initials: MA
authors.lastname: John
authors.affiliation: Department of Internal Medicine, Helen Joseph Hospital, Johannesburg, South Africa.|Division of Clinical Microbiology and Infectious Diseases, National Health Laboratory Services and Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
authors.forename: Martin P
authors.initials: MP
authors.lastname: Grobusch
mesh_terms: D000151:Acinetobacter Infections / Q000175:diagnosis / Q000453:epidemiology / Q000382:microbiology*; D040981:Acinetobacter baumannii / Q000302:isolation & purification*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D002443:Ceftriaxone / Q000627:therapeutic use; D017714:Community-Acquired Infections / Q000453:epidemiology / Q000382:microbiology; D003428:Cross Infection / Q000453:epidemiology / Q000382:microbiology; D003907:Dexamethasone / Q000627:therapeutic use; D006801:Humans; D008297:Male; D016920:Meningitis, Bacterial / Q000175:diagnosis / Q000453:epidemiology / Q000382:microbiology*; D000077731:Meropenem; D008875:Middle Aged; D013845:Thienamycins / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D013845:Thienamycins; D002443:Ceftriaxone; D003907:Dexamethasone; D000077731:Meropenem